Trupanion Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Trupanion in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Trupanion stock.
View analyst ratings for Trupanion or view top-rated stocks.

Wall Street analysts have given Trupanion a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Trupanion wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Trupanion is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for Trupanion.

Trupanion will be holding an earnings conference call on Thursday, August 5th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13720129".

Trupanion, Inc. (NASDAQ:TRUP) issued its earnings results on Thursday, April, 29th. The financial services provider reported ($0.31) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.08) by $0.23. The financial services provider earned $154.69 million during the quarter, compared to analysts' expectations of $151.79 million. Trupanion had a negative net margin of 3.15% and a negative trailing twelve-month return on equity of 7.13%.
View Trupanion's earnings history.

Trupanion's stock was trading at $26.04 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TRUP shares have increased by 337.0% and is now trading at $113.80.
View which stocks have been most impacted by COVID-19.

Trupanion issued an update on its FY 2021 earnings guidance on Monday, May, 10th. The company provided earnings per share (EPS) guidance of - for the period. The company issued revenue guidance of $674 million-$682 million, compared to the consensus revenue estimate of $677.29 million.

5 Wall Street analysts have issued twelve-month price targets for Trupanion's shares. Their forecasts range from $50.00 to $150.00. On average, they anticipate Trupanion's share price to reach $112.50 in the next year. This suggests that the stock has a possible downside of 1.1%.
View analysts' price targets for Trupanion or view top-rated stocks among Wall Street analysts.

139 employees have rated Trupanion CEO Darryl Rawlings on Glassdoor.com. Darryl Rawlings has an approval rating of 76% among Trupanion's employees.

Some companies that are related to Trupanion include Molina Healthcare (MOH), Bright Health Group (BHG), Alignment Healthcare (ALHC), Clover Health Investments (CLOV), Oscar Health (OSCR) and Advanzeon Solutions (CHCR).
View all of TRUP's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Trupanion investors own include CA (CA), Micron Technology (MU), Chipotle Mexican Grill (CMG), McEwen Mining (MUX), Pfizer (PFE), Splunk (SPLK), AbbVie (ABBV), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

Trupanion trades on the NASDAQ under the ticker symbol "TRUP."

Trupanion's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Baillie Gifford & Co. (3.59%), Alliancebernstein L.P. (3.30%), Handelsbanken Fonder AB (0.32%), New York State Common Retirement Fund (0.17%), Thomas Story & Son LLC (0.15%) and Victory Capital Management Inc. (0.10%). Company insiders that own Trupanion stock include Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Howard E Rubin, Margaret Tooth, Michael Doak, Murray B Low, Robin A Ferracone and Tricia Plouf.
View institutional ownership trends for Trupanion.

TRUP stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., and North Star Investment Management Corp.. Company insiders that have sold Trupanion company stock in the last year include Asher Bearman, Dan Levitan, Darryl Rawlings, Gavin Friedman, H Hays Lindsley, Howard E Rubin, Margaret Tooth, Michael Doak, Murray B Low, Robin A Ferracone, and Tricia Plouf.
View insider buying and selling activity for Trupanion or view top insider-selling stocks.

TRUP stock was acquired by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Russell Investments Group Ltd., Empowered Funds LLC, DekaBank Deutsche Girozentrale, Thomas Story & Son LLC, Oppenheimer Asset Management Inc., Envestnet Asset Management Inc., and New York State Common Retirement Fund.
View insider buying and selling activity for Trupanion or or view top insider-buying stocks.

Shares of TRUP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TRUP stock can currently be purchased for approximately $113.80.

Trupanion has a market capitalization of $4.56 billion and generates $502.03 million in revenue each year. The financial services provider earns $-5,840,000.00 in net income (profit) each year or ($0.16) on an earnings per share basis.

Trupanion employs 911 workers across the globe.

The official website for Trupanion is www.trupanion.com.

Trupanion is headquartered at 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108.

Trupanion's mailing address is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. The financial services provider can be reached via phone at (888) 733-2685 or via email at [email protected]